Serious injuries or death may result from the use of these devices. This is a Class I recall, the most serious type of recall.

If your email program has trouble displaying this email, view as a webpage. Integra Recalls CereLink ICP Monitor for Risk of Incorrect Intracranial Pressure Readings Integra is recalling the CereLink ICP Monitor after reports that the device may display incorrect values or out-of-range readings for a patient's intracranial pressure. The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death. Read More Questions? Customers with questions or concerns about this recall should contact their Integra account manager, clinical specialist, or Integra customer service at 1-800-654-2873 or by email at custsvcnj@integralife.com.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA